Selective delivery of TNF to tumor vessels has been achieved by fusing this cytokine with a tumor-vasculature-homing peptide that contains the Cys-Asn-Gly-Arg-Cys (NGR) sequence, a ligand of a CD13 isoform expressed by neo-angiogenic vessels (43, 44). Here, ANPEP is linked to neoplasm.